Stay updated on CD40 Agonist APX005M + Nivolumab in Combo: Clinical Trial

Sign up to get notified when there's something new on the CD40 Agonist APX005M + Nivolumab in Combo: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CD40 Agonist APX005M + Nivolumab in Combo: Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Core content updated with a government funding notice and updated operating-status guidance; version updated from v3.1.0 to v3.2.0.
    Difference
    3%
    Check dated 2025-10-05T10:34:19.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Update the page to a new revision: from v3.0.2 to v3.1.0.
    Difference
    0.1%
    Check dated 2025-09-28T03:22:14.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.
    Difference
    0.2%
    Check dated 2025-09-13T17:38:56.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-06T15:22:06.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of new facility names and locations, as well as a revision to the content related to cancer topics and immunological agents. Notably, the previous version's references to certain cancer types and treatments have been removed.
    Difference
    6%
    Check dated 2025-08-30T12:04:43.000Z thumbnail image
  8. Check
    59 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T04:46:47.000Z thumbnail image

Stay in the know with updates to CD40 Agonist APX005M + Nivolumab in Combo: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CD40 Agonist APX005M + Nivolumab in Combo: Clinical Trial page.